Novelty Seeking Personality Trait
Human personality traits that can be reliably measured by rating scales show a considerable heritable component. One such instrument is the tridimensional personality questionnaire (TPQ), which was designed by Cloninger et al. (1993) to measure 4 distinct domains of temperament--novelty seeking, harm avoidance, reward dependence, and persistence--that are hypothesized to be based on distinct neurochemical and genetic substrates.Risk-taking is a characteristic of behaviors that occur under conditions of uncertainty and involves a tradeoff between beneficial versus detrimental outcomes, perceived or real. Risk-taking may or may not involve conscious evaluation of the probability and magnitude of possible outcomes (Anokhin et al., 2009).See also harm avoidance (OMIM ) and pathologic gambling (OMIM ), which may be related.
Genes related to Novelty Seeking Personality Trait
Clinical FeaturesPhenotypes and symptoms related to Novelty Seeking Personality Trait
- Abnormality of the nervous system
Incidence and onset information— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.
Researches and researchersCurrently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.
Novelty Seeking Personality Trait Recommended genes panels
|Panel Name, Specifity and genes Tested/covered|
Attention deficit-hyperactivity disorder (sequence analysis of DRD4 gene).
By CGC Genetics (Portugal).
By Fulgent Genetics Fulgent Genetics (United States).
You can get up to -6 more panels with our dedicated toolLearn more
Sources and references
You can check the following sources for additional information.OMIM Rare Disease Symptoms Checker
If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TRIGONOCEPHALY 2; TRIGNO2